🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Jette
Clinical trial register · Belgium

Clinical Trials in Jette, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3062 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
3062
Studies in scope
all four open statuses
1741
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Leuven 1265 Brussels 1116 Ghent 1043 Liège 564 Edegem 437
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Universitair Ziekenhuis Brussel35 AbbVie10 AstraZeneca7 Boehringer Ingelheim4 Moens Maarten4
Site location
Leuven1265 Brussels1116 Ghent1043 Liège564 Edegem437
All 201 locations
Target enrolment
to

Trials with a site in Jette

126 of 3062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Not yet open
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
NCT07789015Idiopathic Inflammatory Myopathies
DrugNerandomilast
Boehringer Ingelheim
Phase 3
270
Ghent, Jette, Leuven, Liège
2026-11-09
Not yet open
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
NCT07817875Obesity
DrugTirzepatide
Eli Lilly and Company
Phase 3
150
Brussels, Jette, Leuven
2026-09
Not yet open
PRotEin Provision in Critical IllneSs -2
NCT07529522Critical Illness, Intensive Care (ICU)
Ziekenhuis Oost-Limburg
Not applicable
1,026
Antwerp, Genk, Ghent, Hasselt, Jette, Kortrijk, Leuven, Liège
2026-09
Recruiting
Targeted Temperature Management at 33°C Versus Controlled Normothermia for In-hospital Cardiac Arrest
NCT07086703Cardiac Arrest
Nantes University Hospital
Not applicable
788
Ghent, Jette, Ottignies, Brussels, Charleroi
2026-08-13
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087Systemic Sclerosis
Boehringer Ingelheim
Phase 3
448
Brussels, Ghent, Jette, Leuven, Liège, Yvoir
2026-07-27
Recruiting
Intrathecal Therapy Versus Standard Care for Severe Cancer Pain
NCT07691840Intrathecal Drug Delivery, Refractory Cancer Pain, Conventional Medical Management
Universitair Ziekenhuis Brussel
Not applicable
72
Jette
2026-07-01
Not yet open
Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.
NCT07648381Menstrual Cycle, Luteal Phase Progesterone Levels, Luteal Phase Adaptation, MOCK Cycle
Universitair Ziekenhuis Brussel
Observational
118
Jette
2026-07-01
Not yet open
Chronic Low Back Pain Comorbidities: Unravelling Impaired Glucose Metabolism
NCT07734714Chronic Low Back Pain (Non-specific, Uncomplicated), Chronic Low Back Pain (CLBP)
Vrije Universiteit Brussel
Not applicable
124
Jette
2026-07
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT07525206Colorectal Cancer
DrugsTelisotuzumab Adizutecan·Trifluridine/Tipiracil·Bevacizumab
AbbVie
Phase 3
990
Bonheiden, Edegem, Anderlecht, Brussels, Jette, Charleroi, Yvoir, Ghent
2026-05-22
Not yet open
Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.
NCT07455318Rabies (Healthy Volunteers)
Institute of Tropical Medicine, Belgium
Phase 3
561
Antwerp, Brussels, Ghent, Jette, Liège, Neder-Over-Heembeek
2026-05-15
Recruiting
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
DrugsObrixtamig·Etoposide·Atezolizumab·Carboplatin
Boehringer Ingelheim
Phase 3
670
Brussels, Edegem, Jette, Leuven
2026-04-13
Recruiting
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
NCT07215702Sepsis, Acute Kidney Injury
DrugAZD4144
AstraZeneca
Phase 2
124
Brussels, Genk, Jette, Ottignies
2026-02-10
Recruiting
The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pain
NCT07212829Chronic Widespread Pain, Fibromyalgia (FM)
Vrije Universiteit Brussel
Not applicable
120
Jette
2026-02-01
Recruiting
Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.
NCT07347743Colic, Healthy Infants, Eczema Atopic Dermatitis
Universitair Ziekenhuis Brussel
Not applicable
768
Jette
2026-01-31
Recruiting
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
NCT07332091Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring
Phase 2
84
Ghent, Edegem, Jette, Liège, Yvoir
2026-01-22
Recruiting
Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients
NCT07134673Long COVID, Post-COVID-19 Condition
Universitair Ziekenhuis Brussel
Observational
54
Jette
2026-01-21
Recruiting
Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calories Stick
NCT06923813Post-ICU Patients Fully Enterally Fed
Universitair Ziekenhuis Brussel
Not applicable
20
Brussels, Jette
2026-01-08
Recruiting
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
NCT07218523Bowel Cleansing Prior to Clinical Procedures
DrugsPicoprep·Plenvu
Norgine
Phase 3
212
Edegem, Jette, Alleur
2025-12-29
By invitation
The Effect of a Passive Hip Exoskeleton on Daily-life Fatigue in Older Adults
NCT07359573Fatigue, Older Adults (65 Years and Older)
Vrije Universiteit Brussel
Not applicable
15
Jette
2025-12-11
Recruiting
Assessment of Pulmonary Vein Isolation Using a Balloon Catheter With Pulsed Field Energy in Atrial Fibrillation
NCT07156877Atrial Fibrillation (AF)
Sebastien Knecht
Not applicable
136
Bruges, Jette
2025-12-05
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146Small-cell Lung Cancer
DrugZL-1310
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Edegem, Ghent, Hasselt, Jette, Kortrijk, Libramont, Yvoir
2025-11-30
Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
NCT07187531Type 1 Diabetes
SAb Biotherapeutics, Inc.
Phase 2
159
Jette, Leuven, Liège
2025-11-25
Active, closed
OCT-A Biomarkers for Cognitive Impairment in Patients With Chronic Atrial Fibrillation
NCT07607756OCT Angiography, Atrial Fibrillation (AF), Mild Cognitive Impairment
Universitair Ziekenhuis Brussel
Not applicable
40
Jette
2025-11-10
Recruiting
Intrathecal Pump Refills at Home or at the Hospital
NCT07727798Intrathecal Pump Refill
Moens Maarten
Not applicable
82
Jette
2025-10-15
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
NCT07207811Transthyretin Amyloid Cardiomyopathy (ATTR CM)
DrugNNC6019-0001
Novo Nordisk A/S
Phase 3
1,280
Brussels, Jette, Waterschei-Zwartberg, Aalst, Sint-Gillis-Dendermonde, Antwerp, Bruges, Genk
2025-10-02
Recruiting
Pain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study
NCT07120646Childhood Cancer Survivors
Vrije Universiteit Brussel
Observational
76
Brussels, Jette
2025-10-01
By invitation
The Value of the Turkish Translation of the Four-Dimensional Symptom Questionnaire for Turkish-speaking Patients With Psychological Complaints and Language Barriers.
NCT07653022Depression Anxiety Disorder
Universitair Ziekenhuis Brussel
Not applicable
80
Jette
2025-10-01
Recruiting
Accelerated TMS for Treatment-Resistant ECT
NCT07115628Major Depressive Disorder (MDD)
Universitair Ziekenhuis Brussel
Not applicable
200
Jette
2025-10
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
NCT07007312Acute Myeloid Leukemia (AML)
DrugsZiftomenib·Venclyxto·Ara-C·Venclexta
Kura Oncology, Inc.
Phase 3
1,300
Jette, Ghent, Verviers, Bruges, Roeselare
2025-09-26
Recruiting
ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain
NCT07192965Chest Pain, Acute Coronary Syndromes (ACS)
Universitair Ziekenhuis Brussel
Not applicable
230
Jette
2025-09-10
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer
DrugsCapivasertib·Fulvestrant
Relay Therapeutics, Inc.
Phase 3
540
Antwerp, Brussels, Ghent, Jette, Leuven, Libramont, Liège, Namur
2025-08-26
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT06952803Prostate Cancer
DrugsPrednisolone/Prednisone·Saruparib·Abiraterone
AstraZeneca
Phase 3
700
Brussels, Ghent, Jette, Kortrijk, Leuven, Libramont-Chevigny, Roeselare, Wilrijk
2025-08-06
Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
NCT07088068Type 1 Diabetes Mellitus
DrugTeplizumab
Sanofi
Phase 3
723
Brussels, Edegem, Jette, Leuven, Liège, Namur
2025-08-06
Recruiting
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD
NCT07045948COPD
Universitair Ziekenhuis Brussel
Not applicable
100
Jette
2025-07-14
Not yet open
Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity
NCT06922773Early Life Adversity, Microbiome, Human, Anxiety Symptoms, Depressive Symptoms
Universitair Ziekenhuis Brussel
Observational
50
Jette
2025-05
Recruiting
A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.
NCT07448831Melanoma (Skin Cancer)
DrugPembrolizumab
Universitair Ziekenhuis Brussel
Phase 2
49
Jette
2025-04-17
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277Carcinoma, Non-Small Cell Lung
DrugsRilvegostomig·Keytruda·Pembrolizumab
AstraZeneca
Phase 3
830
Edegem, Jette, Libramont-Chevigny, Liège, Mechelen, Roeselaere
2025-04-10
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Maastricht University
Not applicable
358
Brussels, Antwerp, Ghent, Liège, Yvoir, Hasselt, Jette, Kortrijk
2025-04-01
Not yet open
Sweat Testing in Infants: Comparing Sweat Collection on Upper Vs Lower Limbs
NCT06902363Cystic Fibrosis (CF)
Universitair Ziekenhuis Brussel
Not applicable
20
Jette
2025-03-30
Recruiting
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
NCT06830759Diffuse Large B-cell Lymphoma, Follicular Lymphoma
AbbVie
Observational
700
Brasschaat, Jette, Boussu, Charleroi, La Louvière, Liège, Genk, Sint-Niklaas
2025-03-28
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261Chronic Obstructive Pulmonary Disease (COPD)
DrugTezepelumab
AstraZeneca
Phase 3
990
Genk, Ghent, Jette, Leuven, Mechelen, Namur
2025-03-25
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723Chronic Kidney Disease and Hypertension
DrugBaxdrostat/dapagliflozin
AstraZeneca
Phase 3
5,000
Aalst, Brussels, Genk, Hasselt, Ieper, Jette, Kortrijk, Leuven
2025-03-03
Active, closed
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
NCT06677892Cytomegalovirus (CMV)
Takeda
Observational
66
Anderlecht, Brussels, Edegem, Ghent, Jette, Leuven, Liège, Yvoir
2025-02-24
Recruiting
Options for Lowering the Threshold to Brussels Out-of-hours Primary Care Services for Dutch Speaking Citizens
NCT06700980Communication Barriers, Language, Primary Health Care, After-hours Care
Universitair Ziekenhuis Brussel
Observational
40
Jette
2024-12-10
Recruiting
Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy
NCT05916040Rectal Cancer
Universitair Ziekenhuis Brussel
Observational
35
Jette
2024-11-28
Active, closed
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
NCT06543914Migraine
AbbVie
Observational
1,314
Brussels, Jette, La Louvière, Liège, Aalst, Bruges, Kortrijk
2024-11-26
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
NCT06655155Systemic Sclerosis (SSc)
argenx
Phase 2
81
Ghent, Jette
2024-11-11
Recruiting
Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study
NCT06835907Alcohol Use Disorder (AUD)
Universitair Ziekenhuis Brussel
Not applicable
58
Jette
2024-10-28
Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06417814Metastatic Non-small Cell Lung Cancer
DrugsTagrisso·Datopotamab Deruxtecan·Osimertinib·Pemetrexed
AstraZeneca
Phase 3
744
Charleroi, Edegem, Ghent, Hasselt, Jette, La Louvière, Leuven, Namur
2024-10-04
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Jette, Roeselare, Alken, Bruges, Kortrijk
2024-09-26
By invitation
Transmural Care for Chronically Ill Children: Scientific Guidance and Evaluation of Pilot Projects
NCT06679595Chronic Diseases in Children, Chronic Diseases in Adolescence, Health Personnel, Parents
University Hospital, Ghent
Observational
1,000
Brussels, Charleroi, Edegem, Ghent, Jette, La Louvière, Leuven, Liège
2024-09-10
Active, closed
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824Kidney Disease, Chronic
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
11,000
Bruges, Genk, Jette, Liège
2024-08-30
Active, closed
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT06508658Diffuse Large B-Cell Lymphoma
DrugsEpcoritamab·Lenalidomide·Rituximab·Oxaliplatin
Genmab
Phase 3
379
Jette, Boussu, Yvoir, Leuven, Roeselare
2024-08-13
Recruiting
High Resolution Anuscopy Study
NCT06697964Human Papilloma Virus, Anal Squamous Cell Carcinoma
Universitair Ziekenhuis Brussel
Observational
500
Jette
2024-08-08
By invitation
Targeting Fear of Cancer Recurrence in Cancer Survivors: Evaluation of Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies
NCT06175208Fear of Cancer Recurrence
General Hospital Groeninge
Not applicable
339
Brasschaat, Edegem, Ghent, Leuven, Kortrijk, Bonheiden, Hasselt, Jette
2024-07-03
Active, closed
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06468228Hidradenitis Suppurativa
DrugLutikizumab
AbbVie
Phase 3
1,400
Anderlecht, Brussels, Jette, Charleroi, Ghent, Leuven, Liège
2024-06-27
Recruiting
A Study of Pitolisant in Patients With Prader-Willi Syndrome
NCT06366464Prader-Willi Syndrome
DrugPitolisant
Harmony Biosciences Management, Inc.
Phase 3
134
Jette
2024-05-28
Active, closed
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)
DrugsKeytruda·Pembrolizumab
Inhibrx Biosciences, Inc
Phase 2/3
410
Edegem, Jette, Namur, Sint-Niklaas
2024-05-14
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Brussels, Edegem, Genk, Ghent, Jette
2024-03-13
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Brussels, Edegem, Ghent, Jette, Leuven
2024-02-26
Active, closed
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
NCT06260163Colitis, Ulcerative
DrugsTremfya·Guselkumab
Janssen Research & Development, LLC
Phase 3
112
Charleroi, Ghent, Jette, Leuven
2024-01-19
Active, closed
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
NCT06018337Metastatic Breast Cancer
DrugsDB-1303/BNT323·Nab-paclitaxel·Capecitabine·Paclitaxel
DualityBio Inc.
Phase 3
541
Brussels, Ghent, Jette, Leuven, Liège, Roeselare
2024-01-18
Recruiting
Food Intervention to Reduce Immunotherapy ToXicity
NCT05832606Immune-related Adverse Event, Dietary Habits
Universitair Ziekenhuis Brussel
Not applicable
60
Jette
2024-01-01
Recruiting
Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
NCT06154785Colorectal Surgery, Benign or Malignant Rectal or Colon Tumors
Bordeaux Colorectal Institute Academy
Observational
300
Jette
2023-12-15
Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
NCT06129864Locally Advanced Head and Neck Squamous Cell Carcinoma
DrugVolrustomig
AstraZeneca
Phase 3
1,145
Charleroi, Edegem, Jette, La Louvière, Namur
2023-12-14
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05995353Crohn's Disease
DrugRisankizumab
AbbVie
Phase 3
110
Edegem, Brussels, Jette, Liège, Leuven
2023-12-11
Active, closed
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
NCT05993234HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Aalst, Edegem, Ghent, Haine-Saint-Paul, Hasselt, Jette
2023-12-05
Active, closed
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
NCT05988073Multifocal Motor Neuropathy
argenx
Observational
413
Brussels, Edegem, Ghent, Jette, Leuven, Liège, Woluwe-Saint-Lambert
2023-11-29
Recruiting
Characterization of Left Atrial Substrate in Patients With Ventricular Arrhythmias
NCT06425822Atrial Remodeling
Universitair Ziekenhuis Brussel
Observational
50
Jette
2023-11-08
Recruiting
Feasibility Assessment of Cardiovascular Endurance Training for the Symptomatic Improvement of Irritable Bowel Syndrome Patients With a Sedentary and Non-active Lifestyle.
NCT05680766Irritable Bowel Syndrome
Universitair Ziekenhuis Brussel
Not applicable
30
Jette
2023-10-16
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240Alopecia Areata
DrugUpadacitinib
AbbVie
Phase 3
1,500
Anderlecht, Brussels, Jette, Ghent, Torhout, Liège
2023-10-11
Recruiting
Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
NCT07316465Atopic Dermatitis (AD), Autoantibody, Auto-Immunity, Microbiome, Human
Universitair Ziekenhuis Brussel
Not applicable
500
Jette
2023-10-01
Recruiting
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
NCT06084572GERD
Universitair Ziekenhuis Brussel
Observational
120
Anderlecht, Jette
2023-09-29
Recruiting
Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.
NCT05861609Persistent Spinal Pain Syndrome Type 2, Spinal Cord Stimulation
Moens Maarten
Not applicable
195
Jette, Lier, Roeselare
2023-09-29
Active, closed
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
NCT06088290Leiomyosarcoma
DrugsLurbinectedin·Doxorubicin
PharmaMar
Phase 3
469
Jette, Anderlecht, Brussels, Leuven
2023-09-21
By invitation
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007
NCT06075537Mucopolysaccharidosis II
DrugTividenofusp alfa
Denali Therapeutics Inc.
Phase 2/3
99
Edegem, Jette
2023-09-20
Recruiting
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
NCT05722938Community-acquired Pneumonia
Biotest
Phase 3
590
Aalst, Bruges, Brussels, Edegem, Genk, Ghent, Jette, Liège
2023-09-09
Recruiting
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
NCT05777330Type1 Diabetes Mellitus
Universitair Ziekenhuis Brussel
Not applicable
75
Liège, Bruges, Antwerp, Ghent, Jette, Leuven
2023-08-09
Recruiting
Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause.
NCT05950867Polyneuropathy, Amyloidosis
Universitair Ziekenhuis Brussel
Not applicable
150
Jette
2023-07-28
Active, closed
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
NCT05843643Systemic Lupus Erythematosus
DrugUpadacitinib
AbbVie
Phase 3
1,014
Merksem, Anderlecht, Jette
2023-07-25
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949Psychosis Associated With Alzheimer's Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Jette, Hasselt, Leuven, Roeselare, Alken, Kortrijk
2023-07-11
Active, closed
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
NCT05889182Hidradenitis Suppurativa
DrugUpadacitinib
AbbVie
Phase 3
1,328
Anderlecht, Brussels, Jette, Charleroi, Ghent, Leuven, Liège
2023-06-21
Recruiting
Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease
NCT05697562Hemorrhoids
Universitair Ziekenhuis Brussel
Not applicable
80
Jette
2023-06-01
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT05442567Ulcerative Colitis, Crohn's Disease
DrugVedolizumab
Takeda
Phase 3
240
Edegem, Jette, Leuven
2023-05-16
Recruiting
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
NCT05933239Non-small Cell Lung Cancer
Universitair Ziekenhuis Brussel
Phase 2
20
Jette
2023-03-30
Recruiting
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
NCT05727904Metastatic Melanoma, Unresectable Melanoma, Melanoma
DrugsLifileucel·Pembrolizumab
Iovance Biotherapeutics, Inc.
Phase 3
670
Jette
2023-03-30
Recruiting
Functional Status and Quality of Life in Older Patients Undergoing Robotic Surgery for Colorectal Cancer
NCT05848609Colorectal Surgery, Geriatric Assessment, Quality of Life
Universitair Ziekenhuis Brussel
Not applicable
120
Brussels, Jette
2023-03-15
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Leuven, Jette
2023-01-25
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297Advanced Melanoma
DrugTebentafusp
Immunocore Ltd
Phase 3
540
Brussels, Jette, Leuven
2022-12-19
Active, closed
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
NCT05529316Advanced Melanoma
DrugsBalstilimab·Botensilimab
Agenus Inc.
Phase 2
150
Jette
2022-12-12
Active, closed
Incidence of Graves' Disease After COVID-19 Vaccination
NCT07213141Graves Disease
Laura ICONARU
Observational
161
Brussels, Jette
2022-11-08
Recruiting
Reliability of a Food Frequency Questionnaire in the Assessment of Dietary Intake Including FODMAPs in Different Populations, and Relationship With IBS Symptoms and the Degree of Self-assessed Physical Activity
NCT05293769Irritable Bowel Syndrome
Universitair Ziekenhuis Brussel
Observational
400
Jette
2022-10-15
Recruiting
Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
NCT06683261Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis (CRS)
DrugsOmalizumab·Mepolizumab·Dupilumab
Universitaire Ziekenhuizen KU Leuven
Observational
300
Aalst, Bruges, Brussels, Edegem, Genk, Jette, Leuven, Liège
2022-09-23
Recruiting
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
NCT05169593Crohn Disease
DrugsRisankizumab·Ustekinumab·Vedolizumab·Infliximab
Universitaire Ziekenhuizen KU Leuven
Phase 4
292
Antwerp, Edegem, Brussels, Jette, Tournai, Genk, Liège, Yvoir
2022-09-08
Active, closed
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
NCT05371613Mucopolysaccharidosis II
DrugsIdursulfase·Tividenofusp alfa
Denali Therapeutics Inc.
Phase 2/3
65
Antwerp, Jette
2022-07-21
Recruiting
Return to Work for Persistent Spinal Pain Syndrome Type II Patients
NCT05269212Failed Back Surgery Syndrome, Spinal Cord Stimulation
Moens Maarten
Not applicable
112
Ghent, Hasselt, Jette, Sint-Niklaas, Turnhout
2022-05-10
Active, closed
Precise Procedural and PCI Plan (P4)
NCT05253677Coronary Artery Disease
CoreAalst BV
Not applicable
1,090
Jette, Aalst, Antwerp
2022-04-01
Recruiting
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
NCT04779320Crohn's Disease (CD)
DrugVedolizumab
Takeda
Phase 3
120
Edegem, Jette, Leuven
2022-02-10
Active, closed
Subthreshold SCS or BMT
NCT05169047Failed Back Surgery Syndrome
Moens Maarten
Not applicable
114
Hasselt, Jette, Mechelen, Roeselare, Turnhout
2022-02-07
Recruiting
Efficacy of a Low FODMAP Diet in the Absence of Lactose Malabsorption in Moderate to Severe ROME IV IBS.
NCT05120752Irritable Bowel Syndrome
Universitair Ziekenhuis Brussel
Phase 3
60
Jette
2021-11-02
Rows per page Showing 1–100 of 126
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-belgium/city/jette

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,062 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 126 of those studies with a site in Jette.

How many clinical trials are recruiting in Jette?

77 of the 126 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 8 have not yet opened recruitment, 36 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jette), 126 studies
PhaseStudiesRecruitingShare
Phase 3482938.1%
Not applicable362328.6%
Observational261420.6%
Phase 21097.9%
Phase 2/3302.4%
Phase 1/2211.6%
Phase 4110.8%

Most active sponsors

Lead sponsors with the most studies (Jette)
Lead sponsorStudiesRecruiting
Universitair Ziekenhuis Brussel3527
AbbVie104
AstraZeneca77
Boehringer Ingelheim42
Moens Maarten43
Vrije Universiteit Brussel42
Janssen Research & Development, LLC30
Takeda32
argenx21
Denali Therapeutics Inc.20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.